Khamira Banafsha for the symptomatic treatment of Covid-19 Disease

Authors

  • Mohammad Zakir Assistant Professor, Department of Ilmul Advia (Pharmacology), National Research Institute of Unani Medicine for skin Disorders (NRIUMSD), Hyderabad, India
  • Mohd Naushad Assistant Professor, Department of Ilmul Advia (Pharmacology), Uttranchal Unani Medical College & Hospital, Mustafabad (Padratha), Haridwar, India
  • Wasim Ahmad Assistant Professor, Department of Kulliyyat-e-Tibb, National Institute of Unani Medicine (NIUM), Bangalore, India
  • Tasleem Ahmad Research Officer, Department of Biochemistry, National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD), Hyderabad, India
  • Syeda Hajra Fatima Research Officer, Department of Pathology, National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD), Hyderabad, India
  • Md Aftab Alam Department of Ilmul Advia (Pharmacology), National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD), Hyderabad, India
  • Ghazala Javed Research Officer, Central Council for Research in Unani Medicine, New Delhi, India

DOI:

https://doi.org/10.3329/bjms.v21i4.60262

Keywords:

Antiviral, Antipyretic; Covid-19; Herbal medicine; Khamira Banafsha; Repurposing; Respiratory diseases; Unani medicine

Abstract

Respiratory illness is one of the most important public health problems in many countries worldwide. Even though most of the ailments are treatable with normal care, respiratory-related mortality continues to increase year after year. The global situation is deteriorating as a result of the COVID-19 epidemic. Numerous Unani formulations are beneficial against a variety of respiratory disorders, but they must be clinically researched before they can obtain widespread acceptance in the modern world. At the moment, no antiviral medication is either available for each respiratory disease or is costly and not easy to use in pandemics like COVID-19 on large scale, although Unani medicines may be considered an option. Khamira Banafsha (KB) is a semi-solid blend of three dried flowers, Viola odorata L., Borago officinalis L., and Rosa damascena Mill and the distillate of Rosa damascena, and sugar. The components in this formulation are well-known and frequently utilized in the treatment of respiratory problems.The formulation has been used to treat a wide range of illnesses for decades. This review will discuss the pharmacology, ethnopharmacology, and repurposing of KB as an adjuvant or symptomatic treatment for Covid-19 illness.The chemical composition of the ingredients may be evaluated In-silico to identify their eligibility for Covid-19 disease symptomatic management.

Bangladesh Journal of Medical Science Vol. 21 No. 04 October’22 Page : 883-892

Downloads

Download data is not yet available.
Abstract
122
PDF
56

Downloads

Published

2022-09-11

How to Cite

Zakir, M. ., Naushad, M. ., Ahmad, W. ., Ahmad, T. ., Fatima, S. H. ., Alam, M. A. ., & Javed, G. . (2022). Khamira Banafsha for the symptomatic treatment of Covid-19 Disease. Bangladesh Journal of Medical Science, 21(4), 883–892. https://doi.org/10.3329/bjms.v21i4.60262

Issue

Vol. 21 No. 4 (2022)

Section

Original Articles

License

Copyright (c) 2022 Mohammad Zakir, Mohd Naushad, Wasim Ahmad, Tasleem Ahmad, Syeda Hajra Fatima, Md Aftab Alam, Ghazala Javed

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.